MedTrace Logo

An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes

NCT03417661 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2020-07-22

No results posted yet for this study

Summary

This study evaluates the antimicrobial properties of HEXI-PREP by Clinell compared to both a negative and a positive control product.

Conditions

  • Antimicrobial Effect

Interventions

DRUG

HEXI-PREP By Clinell Wipes

Sterile single sachet wipe containing 3ml solution.

DRUG

Chloraprep

Sterile applicator containing 3ml solution.

DRUG

Placebos

Sterile saline (0.9% w/v) wipe, containing 3ml of solution.

Sponsors & Collaborators

  • Gama Healthcare Ltd.

    lead INDUSTRY

Principal Investigators

  • Daryl Bendel · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2019-06-06
Completion
2019-09-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03417661 on ClinicalTrials.gov